Dr. Arifur Rahman, MBBS, FCPS, FUICC
Clinical Oncologist & Cancer Research Pioneer
My journey into oncology began during my medical school years when I witnessed the profound impact that compassionate, evidence-based care could have on patients facing their greatest challenge. What started as a calling to help others became a lifelong commitment to advancing cancer treatment through both clinical excellence and groundbreaking research.
For over 15 years, I have dedicated my career to not just treating cancer, but to understanding it at its most fundamental level. My approach combines cutting-edge medical science with the deeply human understanding that behind every diagnosis is a person, a family, and a story that deserves our utmost care and attention.
My Philosophy of Care
Every patient deserves personalized treatment that addresses not just their cancer, but their unique circumstances, concerns, and goals.
Precision Over Generalization
I believe that every tumor is unique, and so is every patient. That is why I focus on precision oncology—using advanced genetic insights, molecular profiling, and biomarkers to design treatment strategies tailored specifically to each individual. By moving beyond “one-size-fits-all” approaches, I aim to provide therapies that are more effective, targeted, and personalized.
Innovation with Affordability
Cutting-edge cancer care should never be out of reach. While I embrace the latest advances in targeted treatments and precision medicine, I remain equally committed to making these options accessible. By carefully balancing innovation with cost considerations, I ensure my patients receive the best available therapies without unnecessary financial strain.
Holistic Responsibility in Cancer Care
Cancer treatment is not just about fighting a disease—it is about caring for a person. My philosophy integrates scientific precision with compassion, addressing not only the clinical outcomes but also the emotional and economic well-being of each patient. I see it as my responsibility to deliver care that is advanced, affordable, and deeply human.
Educational Background & Career Milestones
A comprehensive journey through medical education, specialized training, and professional achievements in oncology.
Bangladesh Specialized Hospital PLC
Consultant
Oncology & Radiotherapy, Organization: Bangladesh Specialized Hospital PLC
Labaid Cancer Hospital And Super Specialty Center
Practicing Consultant
Practicing Consultant, Oncology & Radiotherapy, Since January 2022 Organization: Labaid Cancer Hospital And Super Specialty Center
Delta Medical College and Hospitals
Practicing Consultant
Practicing Consultant, Oncology & Radiotherapy, Since April 2020 Organization: Delta Medical College and Hospitals
Bangladesh College of Physicians and Surgeons (BCPS)
FCPS
FCPS, Radiotherapy under BCPS (Bangladesh College of Physicians and Surgeons)
National Institute of Cancer Research & Hospital
MD, Radiation Oncology, Part-1
MD, Part-1, Radiation Oncology at National Institute of Cancer Research & Hospital, Mohakhali for the July 2011 session under university of BSMMU.
Rangpur Medical College & Hospital
MBBS
Obtained MBBS degree from Rangpur Medical College under Rajshahi University
Notre Dame College, Dhaka
Higher Secondary Certificate (HSC)
Passed from Notre Dame College, Dhaka, under Dhaka Board in 1st Division in the year of 1999.
Seroil Govt School, Rajshahi
Secondary School Certificate (SSC)
Passed from Seroil Govt School, Rajshahi, under Rajshahi Board in 1st Division
Medicine Club, Rangpur Medical College Unit
Life Member, MC RpMC Unit
Working with a Student Organization named Medicine Club, presently as Central Advisor & Life Member of RpMC unit
Bangladesh Soceity For Breast Cancer Study
Organisin Secretary, BSBCS
Bangladesh Society for Breast Cancer Study (BSBCS) is a Government registered non-profit organization and its motto is to enhance the level of evidence based practice of breast cancer treatment in Bangladesh.
Hospital Affiliations
Privileged to practice at world-renowned medical institutions committed to excellence in cancer care.
Khwaja Yunus Ali Medical College & Hospital
A. Worked as ‘Assistant Registrar’ from March 2009 to December 2009 and, B. As ‘Medical Officer’ from April 2008 to February 2009,
Green Life Hospital
Worked as ‘Medical Officer’ in Green Life Hospital former New Al-Razi Hospital since September ’06 to December 07.
Showing 4 to 5 of 5 hospital affiliations
Professional Memberships
Active participation in leading medical societies and professional organizations.
MBBS
Member of Bangladesh Medical & Dental Association (BMDC), Registration No- A 43908.
FCPS
Fellow of Bangladesh College of Physicians and Surgeons (BCPS) - ID- 5878
FUICC
Association of Union for International Cancer Control (UICC) Fellows and participated in a Virtual Fellowship with an expert from Amsterdam UMC - Vrije Universiteit Amsterdam, Netherlands in 2021 entitled “Stereotaxy in Oligo-metastatic Disease”
Showing 1 to 3 of 9 professional memberships
Awards & Recognition
Honored to receive recognition from peers and institutions for contributions to cancer care and research.
Wiley Reviewer Certificate
This certificate is awarded to for serving as a reviewer for reviewing 1 manuscript in 2024
2024
BMJ Case Reports Reviewer Certificate
Open as a webpage BMJ Case Reports Dear Md., I wanted to thank you for your time and dedication in reviewing manuscripts for BMJ Case Reports. As a result of your contribution, we are able to continue publishing the best papers that advance science and support healthcare professionals and researchers around the world. In recognition of your contribution, your name has been added to the annual list of reviewers* on the journal website. You can also find other reviewer benefits that BMJ offers on the author hub. Thank you once again, and I hope that you will continue to support the journal in 2023 and beyond. Best wishes, Seema Biswas Editor-in-Chief BMJ Case Reports
2023
BICC 2025
Honered to had Speaking engagement at BICC 2025 at Satellite Symposium by AstraZeneca (MGH) for "Role of Osimertinib in combination with Chemotherapy for EGFR positive Metastatic NSCLC- FLAURA 2 Study with RW Patient"
31 Oct 2025
Speaking Engagements
Sharing knowledge and insights at leading medical conferences worldwide.
10th Asia-Pacific Breast Cancer Summit, March 2022.
Role of neo-adjuvant dual her2 blocker along with chemotherapy for achieving pathological complete response in case of breast cancer patients, a single centre study in Bangladesh. Abstract published in 10th Asia-Pacific Breast Cancer Summit, March 2022.
Sylhet Cancer Congress, Sylhet, Bangladesh, 10 March 2023
Role of HER2 dual blocker along with chemotherapy in case of breast cancer patients in neo-adjuvant, adjuvant and metastatic settings- a single centre experience in Bangladesh with limitation. Oral paper presented in Sylhet Cancer Congress, Sylhet, Bangladesh, 10 March 2023
Dhaka Cancer Summit arranged by Medical Oncology Society of Bangladesh (MOSB) Conference on 8 September 2023.
Pathological Complete Response to Neo-adjuvant Chemotherapy in Triple Negative Breast Cancer- A Single Centre Descriptive Study Experience in a Cross-section of Population. Paper presented in Dhaka Cancer Summit arranged by Medical Oncology Society of Bangladesh (MOSB) Conference on 8 September 2023.
Showing 1 to 3 of 7 speaking engagements
Continuing Medical Education
Committed to lifelong learning and staying at the forefront of medical advances.
ESMO Congress 2022
September 2022ESMO Congress 2022
ESMO Congress 2022
ESMO Congress 2021
September 2021ESMO Congress 2021
ESMO Congress 2021
ESMO Breast Cancer 2021
May 2021ESMO Breast Cancer Virtual Meeting 2021
ESMO Breast Cancer 2021
Showing 19 to 21 of 36 continuing education items
Ready to Begin Your Journey to Recovery?
I'm here to provide the compassionate, expert care you deserve. Let's work together to develop a personalized treatment plan that gives you the best possible outcome. Key Treatment Areas Breast Cancer Lung Cancer Ovarian & Gynecologic Cancer Gastrointestinal Cancer Genitourinary (Prostate, Bladder, Kidney) Neuro-oncology “Learn how we tailor treatment using biomarkers, targeted agents, and immunotherapy.”